Pharma Intelligence is part of the Business Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Specialist reporter
+41 year(s) experience
Pink Sheet
By Sten Stovall 05 Apr 2017
Biogen's chief medical officer says iPhone technology should in future be used for early warning diagnosis of Alzheimer's Disease.
Topic Alzheimers
Pink Sheet
By Sten Stovall 05 Apr 2017
Neurotrope's novel bryostatin treatment for Alzheimer's, AstraZeneca's durvalumab in bladder cancer, and Actelion’s antibiotic cadazolid are among a raft of therapies scheduled for major data read-outs or approval decisions in Q2 2017. With the help of Informa Pharma Intelligence’s Biomedtracker, Scrip takes a look at some crucial drug displays likely over the next three months.
Topic Alzheimers Cancer Clinical trials
Pink Sheet
By Sten Stovall 15 Mar 2017
Discussion with regulators on conditional regulatory pathways will now begin after strong and durable immune responses against the Zaire Ebola virus were reported in a UK-based Phase I trial in healthy volunteers usingthefiloviruses vaccine Ad26.ZEBOV developed by Bavarian Nordic AS and licensed by Johnson & Johnson'sJanssen Pharmaceutical Cos.
Topic Rare Disease Research
Scrip
02 May 2017
Pink Sheet
01 May 2017
Scrip
27 Apr 2017
Scrip
25 Apr 2017
Scrip
24 Apr 2017
Scrip
20 Apr 2017
Scrip
19 Apr 2017
Scrip
18 Apr 2017
Scrip
13 Apr 2017
Scrip
11 Apr 2017
Scrip
10 Apr 2017
Scrip
06 Apr 2017
Scrip
05 Apr 2017
Scrip
03 Apr 2017
Pink Sheet
31 Mar 2017
